Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China flag China · Delayed Price · Currency is CNY
10.14
+0.16 (1.60%)
At close: May 8, 2026

SHE:301301 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
664.17734.211,088760.941,632510.05
Trading Asset Securities
----1.151.21
Cash & Short-Term Investments
664.17734.211,088760.941,633511.26
Cash Growth
-41.89%-32.54%43.03%-53.41%219.44%0.13%
Accounts Receivable
2,0111,7851,5721,4031,4171,178
Other Receivables
0.910.280.530.632.591.19
Receivables
2,0121,7851,5731,4041,4201,179
Inventory
1,3221,5001,3421,6761,3841,453
Other Current Assets
192.81189.69141.02114.9491.2572.12
Total Current Assets
4,1914,2094,1443,9564,5283,216
Property, Plant & Equipment
5,6685,7316,0465,8705,5395,920
Long-Term Investments
252.93202.270.696.786.93-
Goodwill
1.371.371.371.371.371.37
Other Intangible Assets
236.68228.91235.83257.99283.07271.83
Long-Term Deferred Tax Assets
20.1721.7720.921.6511.346.96
Long-Term Deferred Charges
0.440.661.542.423.44.72
Other Long-Term Assets
32.0534.6633.2521.6417.9740.94
Total Assets
10,40310,42910,55410,13910,3909,462
Accounts Payable
695.59262.62383.33479.98282.99427.66
Accrued Expenses
27.5940.3664.3231.5766.3220.7
Short-Term Debt
760.48560.35210.15850.68978.83700.35
Current Portion of Long-Term Debt
10.56146.11608.16538.36847.26878.17
Current Portion of Leases
-10.468.93.81.881.02
Current Income Taxes Payable
89.9233.8866.3736.5224.790.14
Current Unearned Revenue
15.2719.2366.8228.943821.26
Other Current Liabilities
31.69671.36539.49565.85467.33513.58
Total Current Liabilities
1,6311,7441,9482,5362,7072,563
Long-Term Debt
--146357.331,4282,092
Long-Term Leases
448.06469.73451.12188.1210.23.13
Long-Term Unearned Revenue
100.06103.892.5183.7434.2426.22
Long-Term Deferred Tax Liabilities
---0.310.08-
Other Long-Term Liabilities
5.273.74-0.08--
Total Liabilities
2,1842,3222,6373,1654,1804,684
Common Stock
2,2302,2302,2272,2232,2232,000
Additional Paid-In Capital
3,2993,2983,2843,2523,2292,431
Retained Earnings
2,6652,5542,3861,486752.21340.7
Comprehensive Income & Other
0.190.19-0.1---
Total Common Equity
8,1948,0827,8986,9606,2044,771
Minority Interest
24.6625.3718.8312.8766
Shareholders' Equity
8,2188,1087,9166,9736,2104,777
Total Liabilities & Equity
10,40310,42910,55410,13910,3909,462
Total Debt
1,2191,1871,4241,9383,2663,675
Net Cash (Debt)
-554.94-452.44-336-1,177-1,633-3,163
Net Cash Per Share
-0.25-0.20-0.15-0.53-0.83-1.70
Filing Date Shares Outstanding
2,2302,2302,2272,2232,2232,000
Total Common Shares Outstanding
2,2302,2302,2272,2232,2232,000
Working Capital
2,5602,4652,1971,4211,820653.24
Book Value Per Share
3.673.623.553.132.792.39
Tangible Book Value
7,9567,8527,6606,7015,9204,498
Tangible Book Value Per Share
3.573.523.443.012.662.25
Buildings
-3,1863,0602,7792,6372,560
Machinery
-6,3466,2265,8615,8155,725
Construction In Progress
-277.21285.31537.860.1296.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.